BankPlus Trust Department’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$594K Sell
9,468
-386
-4% -$30.9K 0.16% 115
2025
Q4
$940K Buy
9,854
+58
+0.6% +$5.69K 0.25% 87
2025
Q3
$956K Sell
9,796
-375
-4% -$38.8K 0.26% 79
2025
Q2
$1.09M Buy
10,171
+1,776
+21% +$180K 0.32% 70
2025
Q1
$847K Buy
8,395
+157
+2% +$15.8K 0.28% 74
2024
Q4
$736K Buy
+8,238
New +$725K 0.24% 84

Other funds holding BSX

BankPlus Trust Department's BSX Position: Q1 2026 in Review

BankPlus Trust Department reduced its Boston Scientific (BSX) stake by 3.9% in Q1 2026, selling an estimated $30.9K and leaving 9,468 shares worth $594K. The position accounts for 0.16% of the portfolio, ranked #115.

BankPlus Trust Department first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.09M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • BankPlus Trust Department held 9,468 shares of Boston Scientific worth $594K as of Q1 2026.
  • BankPlus Trust Department sold 386 Boston Scientific shares in Q1 2026, an estimated $30.9K.
  • Boston Scientific made up 0.16% of BankPlus Trust Department's portfolio in Q1 2026, its #115 holding.
  • BankPlus Trust Department first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • BankPlus Trust Department's Boston Scientific position peaked at $1.09M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BankPlus Trust Department's 13F filing for Q1 2026, filed 11 May 2026.